UNSPSC 42295525: Biological tissue implants

In this classification, this commodity indicates a product used as a biological tissue implant used in a surgical implantation procedure in a medical setting Most nations, for tariff and trade purposes, schedule these products under HS 901839.

UNSPSC 42295525 Biological tissue implants is a Commodity code under which state and local health systems, teaching hospitals, and research institutions are actively soliciting implantable medical devices—particularly cardiac rhythm management devices, spinal implants, and related surgical instrumentation. The code captures procurement of FDA-approved or CE-certified implants including pacemakers, implantable cardioverter-defibrillators, cardiac resynchronization therapy devices, spinal fusion constructs, artificial discs, pedicle screws, and associated fixation hardware. State and local buyers under this code include academic medical centers operated by county hospital districts, university health systems within state research institutions, and cooperative purchasing vehicles serving multiple jurisdictions. The University Medical Center of El Paso and the University of Texas Health Science Center at San Antonio are active repeat solicitors of implantable devices on RFP vehicles, while Sourcewell, a Minnesota-based state and local cooperative, recently issued a broad law enforcement equipment RFP that appears misaligned with the biological tissue implant scope.

Recent activity concentrates in Texas, where the University of Texas Health Science Center at San Antonio issued RFP 745-26-P04 for spinal implants and related surgical supplies on a bill-only basis for its newly opened 144-bed Multispecialty and Research Hospital (response deadline March 10, 2026), and the University Medical Center of El Paso issued RFP 784-03-26-001 for a dual-vendor cardiac rhythm management implant framework covering pacemakers, ICDs, CRT devices, and leadless pacemakers (response deadline April 29, 2026, with a virtual pre-submittal meeting on April 7, 2026). Both Texas opportunities involve multi-awarded contracting and weighted evaluation on clinical product quality, physician experience, cost, vendor support, and portfolio comprehensiveness. The UTHSA spinal implant solicitation mandates submission of a Historically Underutilized Business Subcontracting Plan and requires vendors to meet a five-year minimum experience threshold; the El Paso cardiac device RFP includes no stated set-asides or incumbent vendor information. Both opportunities reflect high-volume surgical demand at major teaching hospitals and position vendors to serve broader networks if host institutions expand purchasing arrangements to other system members.